THAT — Thalia Therapeutics Share News
0.000.00%
Last trade - 00:00- £11.10m
- £9.59m
- £0.01m
Notice of GM and Proposed Change of Name
Brief: N4 Pharma PLC Appointes David H Solomon As CEO
CEO Appointment & Name Change Thalia Therapeutics
Business and Operational Update
Brief: N4 Pharma H1 Basic EPS GBP -0.0009
Interim Results
Notice of Results, Analyst & Investor Presentation
Investor Event and Presentation
Article on Nuvec®’s Potential in RNA Therapeutics
Investor Webinar
Directorate Change
AGM Statement
Insight Event for Retail Investors
Final Results, Annual Report and Notice of AGM
Establishment of New Senior Leadership Team
TR-1: Notification of major holdings
Holding(s) in Company
Brief: N4 Pharma Announces Positive Results From In Vivo Study Of Nuvec
N4 101 In Vivo Study Results